CBBS - 916-560-8536
SCABB - 866-649-6550

April 25 - 28, 2018
Renaissance Phoenix Glendale

Educational Sessions

Thursday, April 26

8:00 - 9:30 AM

Patient Blood Management

​Technical/Scientific

How do you implement a therapeutic phlebotomy clinic?  ​​​​​​​​​​​​​​Rich Gammon, MD, ​In the face of decreasing revenue from declining blood use and inability to pass along ever increasing costs of producing safe blood to hospitals, blood centers are looking for additional sources of revenue to maintain a positive bottom line. This lecture will discuss implementation of a therapeutic phlebotomy clinic whose purpose is to treat patients with diagnoses not eligible for transfusion of collected products. Challenges prior to implementation will be disused. The lecture will conclude with future directions

CBBS Ledin Award Lecture

Creating an Engaged Workforce 

​Administrative

Creating an Engaged Workforce Through Leadership Coaching, ​​​​​​​​​​​​Lisa Robinson  In this interactive leadership workshop, you'll have the opportunity to learn and practice the key coaching skills of:  Powerful questions, managing vs. coaching mindset, active listening, managing assumptions, and self awareness.  You will also leave with a plan to teach these skills to your leaders and teams when you're back at work after the conference.   

Determining Total Blood Volume & Ethics

Apheresis Nursing

How to Determine Total Blood Volume and Perform Apheresis Safely in Certain Patient/Donor Populations, ​​​​​​​​​​​Liz Rosenbaum-Marinaro, MD 
Ethics in Apheresis, ​​​​​​​​Andrew Jones, MD 

9:45 - 11:15 AM

Treatment of Bleeding Disorders

​Technical/Scientific

DOAC Therapy, CV Surgery, and Managing Bleeding, ​​​​​​​​​​​​​Alice Chen, MD, PhD, Newer anticoagulant and antiplatelet agents present significant challenges to planning and performing CV surgery. An overview of these medications, reversal agents, and a practical approach to managing bleeding in the perioperative setting will be presented.
Hemostatic Efficacy of Fibrinogen Concentrate Compared to Cryoprecipitate, Anil Panigrah.  Fibrinogen plays a critical role in hemostasis and there is increased understanding of the risk from acquired hypofibrinogenemia that occurs during acute trauma and in surgical patients. As a result, several studies have supported early fibrinogen replacement to improve hemostasis. Standard fibrinogen replacement involves transfusion of cryoprecipitate, however, there continues to be concerns regarding the safety of allogeneic blood products. With its increasing availability, lyophilized fibrinogen concentrates may serve as a safer, efficacious alternative. In this presentation, the benefits of fibrinogen replacement will be reviewed and the safety and clinical efficacy of fibrinogen concentrates relative to cryoprecipitate will be discussed.

Hiring/Generational Management

​Administrative

Hiring/Generational Management, ​​​​​​​​​​​Steve Ferraiuolo, Rob Van Tuyle, & James Giacoletti.  Discussion around how the executive team at blood centers has changed over the years and what tools are necessary for leaders of the future.

Therapeutic Apheresis Case Studies

​Apheresis Nursing

Theraputic Apheresis Case Studies & Leukodepletions using the Optia/Saying Goodbye to the Spectra, ​​​​​​​​​​​​​Paul Eastvold, MD, MT(ASCP), Liz Rosenbaum-Marinaro, MD   Will present several case studies related to the use of plasma exchange to treat disorders such as TTP, aHUS and other autoimmune diseases.  Will also present the changing leukopheresis platform change from the good ole Spectra to the new faster Optia.

1:00 - 2:30 PM

Regulatory and Policy Changes 

​Technical/Scientific

Regulatory and Policy Changes , ​​​​​​​​​​​​​Barbara Bryant, MD  
Contemporary Legal and Ethical Concerns in Blood Banking, Kathleen Sazama, MD, JD.  Introduction of legal issues and ethical concerns that affect all of blood banking and transfusion medicine, citing specific examples. Discuss contemporary dilemmas with potential legal or ethical implications that may affect policy decisions.

Leadership/Succession Planning

​Administrative

Leadership/Succession Planning, ​​​​​​​​​​​​Laura Eickhoff  

Therapeutic Apheresis Case Studies

​Apheresis Nursing

Differences between Spectra and Optia , ​​​​​​​​​​​​​Paul Eastvold, MD, MT(ASCP).   Will present several case studies related to the use of plasma exchange to treat disorders such as TTP, aHUS and other autoimmune diseases.  Will also present the changing leukopheresis platform change from the good ole Spectra to the new faster Optia.
CVC Care and Nursing Best Practices (CLABIS)

2:45 - 4:15 PM

Case Studies 

​Technical/Scientific

Dueling Consents , ​​​​​​​​​​​​​Richard Gammon, MD.  The case study will review how clerical errors can occur with patient consent. It will show that there is a lack of understanding between patients and their providers on items discussed prior to transfusion.  
An Unexpected Case of Post-transfusion Purpura, Jennifer Woo, MD This case presentation highlights an unexpected case of post-transfusion purpura (PTP) occurring in the post-operative setting. The discussion will review the differential diagnosis of unexplained thromobocytopenia, laboratory methods to diagnose PTP, and treatment options for PTP patients. 
Blood Donation during Pregnancy Due to Anti-Ku HDFN , ​​​​​​​​​​​​​Mrigender Virk, MD,  A case of hemolytic disease of the fetus and newborn (HDFN) was identified during a female's first pregnancy and was found to be caused by anti-Ku and anti-D. Due to the extremely rare phenotype of the mother and difficulty obtaining blood for the fetus, a bedside blood donation was done in the mother's hospital room.

Customer Service

​Administrative

Customer Service, ​​​​​​​​​​​​PJ Geraghty 

Therapeutic Apheresis Case Studies

​Apheresis Nursing

Photopheresis in the Blood Bank Setting , ​​​​​​​​​​​​​Salima Shaikh, MD.   The principles and technology of photopheresis will be discussed, along with advantages, benefits, and challenges of implementing photopheresis at the blood center.
Short Term and Long Term Complications of Frequent Apheresis Donation, Jonathan Hughes, MD.  An overview of complications that may be experienced by frequent apheresis donors will be presented.

Friday, April 27

8:00 - 9:30 AM

Immunohematology/Molecular/ Perkins-Garratty Lecture

​Technical/Scientific

Fetal blood grouping by analysis of fetal DNA in maternal blood , ​​​​​​​​​​​​​Geoff Daniels BSc, PhD, FRCPath.  Plasma from pregnant women contains a small quantity of cell-free fetal DNA, which can be used to determine the blood groups of their fetus. In pregnant women with anti-D, knowledge of fetal D type informs the clinician whether the baby is at risk from HDFN. Also, if all D-negative pregnant women are tested, those with a D-negative fetus can be saved from unnecessary prophylactic treatment with anti-D immunoglobulin. This testing is provided routinely in several countries and being introduced in others, but is seldom performed in the USA. Is this a service that should be considered for the future?
Progress in Blood Safety, Steven Kleinman, MD .  Blood safety has dramatically improved over the last three decades with both infectious and noninfectious risks decreasing. Decision making paradigms have also evolved, albeit more slowly. This presentation will use several specific examples to illustrate these points.

CBBS Perkins-Garratty Lecture

Reportable or Not

QSC

Reportable or Not, ​​​​​​​​​​​​Karen Dosanjh.   An interactive presentation and discussion on events that may or may not be reportable to the FDA via the Biological Product Deviation Reporting process.  

Round Tables

DRC

How to Increase Appointments; Targeting New Donors; Social Media, ​​​​​​​​​​​​​​Erin Frye, Tirzah Zielinski.  ​ Round Table Discussion

9:45 - 11:15 AM

Innovations/Cellular Therapy

​Technical/Scientific

Innovations/Cellular Therapy , ​​​​​​​​​​​​​Shibani Pati, Suchi Pandey.  

Change Control & Validation

QSC

Best Practices in Change Control - Simplicity and Scalability, ​​​​​​​​​​​​​Adrienne Mendoza, CQA, CSSGB   Review Case Study of Improvements to the Change Control Programs BioBridge Global Subsidiaries, including South Texas Blood and Tissue Services. 

 BioLinked/ Global Blood Fund Program/ Thank the Donor Program 

DRC

BioLinked, ​​​​​​​​​​​​​Charles Mooney, MBA, MS, MT(ASCP)SBB, 6-Sigma Black Belt

12:30 - 2:00 PM

Pathogen-reduced Platelets Implementation

​Technical/Scientific

An Example of Implementation of Intercept Platelets , ​​​​​​​​​​​​​Mary Berg, MD.  This presentation will describe the process used to implement pathogen-reduced platelets at an academic medical center.
Pathogen reduction technology in a hospital based blood center, Dawn Ward, MD.  Dr. Ward will discuss the implementation and routine use of pathogen reduced platelets while maintaining a dual inventory with conventional (non-pathogen reduced) platelets. 

Error Proofing 

QSC

Using Human Factor Analysis to Reduce Errors, ​​​​​​​​​​​​​Karen Dosanjh, Theresa Dunning, MSQA, MT(ASCP)SBB, CMQ/OE(ASQ).   This work shop will discuss the use of Human Factor Error Analysis to reduce human error. Analysis of Human Error due to System design gaps or Human performance limitations will be presented from the perspective of a Blood Center and Transfusion Service ​.

Iron Mitigation from the Recruitment Perspective

DRC

Jonathan Hughes, MD

2:15 - 3:45 PM

Collaborations Between Blood Center and Transfusion Service

​Technical/Scientific

Forecasting Platelet Transfusion Need from Hospital Big Data , ​​​​​​​​​​​​​Tho Pham, MD.  Daily blood product use is difficult to anticipate. Platelet products are the most variable in daily usage, have short shelf lives, and are also the most expensive to produce, test, and store, and are frequently wasted due to expiration. We have investigated platelet usage patterns at our institution, and specifically interrogated the relationship between platelet usage and aggregated hospital-wide patient data over a recent consecutive 29-mo period. We have found that platelet usage is highly dependent on key patient variables. We incorporated these relationships in a mathematical model to guide collection and ordering strategy. This model minimizes waste due to expiration while avoiding shortages. Compared with historical expiration rates during the same period, our model reduces the expiration rate from 10.5 to 3.2%.
Supplying Blood in Special Environments, Samantha Ngamsuntikul, MD.  Historically, blood centers have provided blood to hospitals. Recently, our center has received requests for stocking blood on helicopters and emergency centers. The presentation is a discussion of our experiences.

Disaster Ops: Preparing for the Unexpected

QSC

Preparing for the Next Disaster (and the next...and the next), ​​​​​​​​​​​​​Garrick "Rick" Chatelain, BS, MT(ASCP).   Natural and man-made disasters seem to be on the rise. With each one, we learn new lessons, but each disaster is different. Are there any common themes that can be used to prepare for all disasters?

Community Leadership from a Volunteer Perspective

DRC

Increasing High School Productivity, Ashley Herman, MS.  The presentation is intended to create dialog on unique methods to increase collections at High School Blood Drives.
Community Leadership From a Volunteer Perspective, Joe Ayer, MBA.  Have you ever wondered how to motivate your community to be more engaged with your organization?   In this presentation you will learn how to leverage volunteer leadership within your community to inspire more depth in your constituency leading to better outcomes.   

4:00 - 5:30 PM

Ask the Experts

​Technical/Scientific

Kathleen Sazama, MD, JD, Geoff Daniels BSc, PhD, FRCPath

Saturday, April 28

8:00 - 9:00 AM

MD Roundtable

​Technical/Scientific

Kathleen Sazama, MD, JD, Geoff Daniels BSc, PhD, FRCPath

9:15 - 10:45 AM

SCABB Award Lectures

Awards/Plenary

Technical/Scientific Award Lecture:  Blood group diversity and its impact on transfusion medicine, ​Geoff Daniels BSc, PhD, FRCPath  Blood group antigens exhibit a wide structural diversity, including peptide antigens on proteins and carbohydrate epitopes on glycoproteins and/or glycolipids. Glycoproteins are inserted within the membrane via single or multiple trans-membrane domains, or via glycosylphosphatidylinositol linkages. Blood group antigens provide a variety of physiological functions, including membrane transport, adhesion and receptor functions, enzyme activity, complement regulation, anchoring the membrane to the cytoskeleton, and contributing to the glycocalyx. This presentation will also review the diversity of blood group antibodies in relation to their clinical importance in haemolytic transfusion reactions and haemolytic disease of the fetus and newborn.


10:45 - 11:45 AM

 Karen Williams Memorial Lecture

Awards/Plenary

Richard J. Benjamin MBChB, PhD, FRCPath